Smithkline Beecham Limited
- Company number
- 02337959
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 24 Jan 1989
- Nature of business
- Manufacture of basic pharmaceutical products
Activities of other holding companies n.e.c. - Corporate group
- GMV Nominees Ltd (48362 companies)
Registered office
Previous names
- Smithkline Beecham P.L.C. (until 27 Oct 2009)
- Goldslot Public Limited Company (until 7 Apr 1989)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| OLIINYK, Dmytro | Director | 19 Feb 2022 | 16 Jul 2026 |
| BUTLER, Robert William | Director | 16 Jul 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Glaxosmithkline Finance Plc | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
6 Apr 2016 |
Accounts
Connections
Owned by
Smithkline Beecham Limited → Glaxosmithkline Finance PLC → Glaxosmithkline Holdings Limited → GSK PLC
Controls
- Beecham Group PLC (00227531)
- Dealcyber Limited (03541898)
- Eskaylab Limited (00099025)
- Glaxosmithkline Capital PLC (02258699)
- Glaxosmithkline Caribbean Limited (00522215)
- Smithkline Beecham (Export) Limited (02860752)
- Smithkline Beecham (Investments) Limited (00302065)
- Smithkline Beecham Legacy H Limited (00210281)
- Smithkline Beecham Marketing And Technical Services Limited (00494385)
- Smithkline Beecham Nominees Limited (00503868)
Directors’ other companies
- BUTLER, Robert William - Director at Glaxo Operations UK Limited
Companies at the same address
- Aiolos Bio Limited (14956089)
- Allen & Hanburys Limited (00040209)
- Beecham Group PLC (00227531)
- Berkeley Square Common Investment Fund (No. 2) Limited (06273783)
- Berkeley Square Common Investment Fund Limited (05269762)
- British Pharma Group Limited (02538510)
- Burroughs Wellcome International Limited (00543757)
- Clarges Pharmaceuticals Trustees Limited (01418508)
- Dealcyber Limited (03541898)
- Eskaylab Limited (00099025)